Ghent University Academic Bibliography

Your filters: cql: author="Jerusalem, Guy" or (type any "bookEditor issueEditor" and editor="Jerusalem, Guy")

Add to list
- Journal Article
- A1
- open access
Autogene cevumeran with or without atezolizumab in advanced solid tumors : a phase 1 trial

Juanita Lopez, Thomas Powles, Fadi Braiteh, Lillian L. Siu, Patricia LoRusso, Claire F. Friedman, Ani S. Balmanoukian, Michael Gordon, Jeffrey Yachnin, Sylvie Rottey (UGent) , et al.

(2025) NATURE MEDICINE. 31(1). p.152-164
Add to list
- Journal Article
- A2
- open access
Expected medium- and long-term impact of the COVID-19 outbreak in oncology

Concetta Elisa Onesti, Marco Tagliamento, Giuseppe Curigliano, Nadia Harbeck, Rupert Bartsch, Hans Wildiers, Vivianne Tjan-Heijnen, Miguel Martin, Sylvie Rottey (UGent) , Daniele Generali, et al.

(2021) JCO GLOBAL ONCOLOGY. 7. p.162-172
Add to list
- Journal Article
- A1
- open access
Anthracyclines strike back : rediscovering non-pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer

Francesco Schettini, Mario Giuliano, Matteo Lambertini, Rupert Bartsch, David James Pinato, Concetta Elisa Onesti, Nadia Harbeck, Diana Lueftner, Sylvie Rottey (UGent) , Peter A. van Dam, et al.

(2021) CANCERS. 13(17).
Add to list
- Journal Article
- A1
- open access
Oncological care organisation during COVID-19 outbreak

Concetta Elisa Onesti, Hope S. Rugo, Daniele Generali, Marc Peeters, Khalil Zaman, Hans Wildiers, Nadia Harbeck, Miguel Martin, Massimo Cristofanilli, Javier Cortes, et al.

(2020) ESMO OPEN. 5(4).
Add to list
- Conference Paper
- C3
A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors

Juanita S. Lopez, Ross Camidge, Marco Iafolla, Sylvie Rottey (UGent) , Martin Schuler, Matthew Hellmann, Ani Balmanoukian, Luc Dirix, Michael Gordon, Ryan Sullivan, et al.

(2020) CANCER RESEARCH. 80(16).
Add to list
Pharmacokinetic effects and safety of olaparib administered with endocrine therapy : a phase I study in patients with advanced solid tumours

Ruth Plummer, Henk M. Verheul, Filip Y. F. L. De Vos, Karin Leunen, L. Rhoda Molife, Christian Rolfo, Peter Grundtvig-Sørensen, Jacques De Grève, Sylvie Rottey (UGent) , Guy Jerusalem, et al.

(2018) ADVANCES IN THERAPY. 35(11). p.1945-1964
Add to list
Effect of itraconazole and rifampin on the pharmacokinetics of olaparib in patients with advanced solid tumors : results of two phase I open-label studies

Luc Dirix, Helen Swaisland, Henk MW Verheul, Sylvie Rottey (UGent) , Karin Leunen, Guy Jerusalem, Christian Rolfo, Dorte Nielsen, L Rhoda Molife, Rebecca Kristeleit, et al.

(2016) CLINICAL THERAPEUTICS. 38(10). p.2286-2299
Add to list
Tissue factor induced by epithelial-mesenchymal transition triggers a procoagulant state that drives metastasis of circulating tumor cells

Morgane Bourcy, Meggy Suarez-Carmona, Justine Lambert, Marie-Emilie Francart, Hélène Schroeder, Céline Delierneux, Nicolas Skrypek (UGent) , Erik W Thompson, Guy Jérusalem, Geert Berx (UGent) , et al.

(2016) CANCER RESEARCH. 76(14). p.4270-4282
Add to list
- Journal Article
- A1
- open access
Cancer risk in immune-mediated inflammatory diseases (IMID)

Rudi Beyaert (UGent) , Laurent Beaugerie, Gert Van Assche, Lieve Brochez (UGent) , Jean-Christophe Renauld, Manuelle Viguier, Veronique Cocquyt (UGent) , Guy Jerusalem, Jean-Pascal Machiels, Hans Prenen, et al.

(2013) MOLECULAR CANCER. 12.
Add to list
Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)

Rosa Giuliani, Virginie Durbecq, Angelo Di Leo, Marianne Paesmans, Denis Larsimont, Jean-Yves Leroy, Marleen Borms, Anita Vindeuoghel, Guy Jerusalem, Veronique D'Hondt, et al.

(2007) EUROPEAN JOURNAL OF CANCER. 43(4). p.725-735

Academic Bibliography

Autogene cevumeran with or without atezolizumab in advanced solid tumors : a phase 1 trial

Expected medium- and long-term impact of the COVID-19 outbreak in oncology

Anthracyclines strike back : rediscovering non-pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer

Oncological care organisation during COVID-19 outbreak

A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors

Pharmacokinetic effects and safety of olaparib administered with endocrine therapy : a phase I study in patients with advanced solid tumours

Effect of itraconazole and rifampin on the pharmacokinetics of olaparib in patients with advanced solid tumors : results of two phase I open-label studies

Tissue factor induced by epithelial-mesenchymal transition triggers a procoagulant state that drives metastasis of circulating tumor cells

Cancer risk in immune-mediated inflammatory diseases (IMID)

Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)

Contents

Support

Contact